BRIEF published on 11/06/2025 at 13:05, 6 months 5 days ago Moderna annonce un chiffre d'affaires d'un milliard de dollars au troisième trimestre 2025, malgré des prévisions financières revues à la baisse pour 2025. Résultats Financiers Moderna Baisse Des Revenus Vaccin Contre Le Covid-19 Efficacité En Matière De Coûts
PRESS RELEASE published on 11/06/2025 at 13:00, 6 months 5 days ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 6 months 8 days ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
BRIEF published on 11/03/2025 at 13:05, 6 months 8 days ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
PRESS RELEASE published on 11/03/2025 at 13:00, 6 months 8 days ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 6 months 19 days ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 6 months 19 days ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 6 months 19 days ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 6 months 19 days ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
BRIEF published on 10/23/2025 at 13:05, 6 months 19 days ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
Published on 05/12/2026 at 06:00, 5 hours 35 minutes ago NOA Lithium Announces Strategic Collaboration with Hidrotec to Support NOA Projects
Published on 05/12/2026 at 04:20, 7 hours 15 minutes ago AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
Published on 05/12/2026 at 03:05, 8 hours 30 minutes ago UraniumX Reports Tragic Incident at Its Zoo Bay Property
Published on 05/12/2026 at 00:00, 11 hours 35 minutes ago PPX Mining Provides Update on Start-up of the Process Plant
Published on 05/12/2026 at 00:00, 11 hours 35 minutes ago Redwood AI Included in Innovate BC Investor Showcase: BC's Top 25 Investible Companies Event
Published on 05/12/2026 at 10:15, 1 hour 19 minutes ago EQS-Adhoc: aconnic AG announces improved fund raising plan to support business and refinance debt
Published on 05/12/2026 at 10:05, 1 hour 29 minutes ago Green Street Launches Green Street Infrastructure, Setting a New Standard for Real Assets Intelligence
Published on 05/12/2026 at 08:30, 3 hours 5 minutes ago Eiffage annonce le démarrage des travaux de construction du pôle universitaire du campus Grand Paris Nord à Saint-Ouen-sur-Seine
Published on 05/12/2026 at 08:30, 3 hours 5 minutes ago Eiffage announces launch of the construction work on the university hub of the Grand Paris Nord campus in Saint-Ouen-sur-Seine
